Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…
Pfizer scraps weight loss pill after liver injury
Just as Pfizer was hoping to ride the obesity drug wave into a new era of post-Covid prosperity, the pharmaceutical titan has slammed the brakes on its most high-profile weight…








